This inventor holds 1 USPTO granted patent. Top assignee: Obi Pharma Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: I-Ming Cho: Innovator in Protein Expression Technology
Introduction
I-Ming Cho is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression. His work has implications for various applications, including vaccine development and therapeutic proteins.
Latest Patents
I-Ming Cho holds a patent for the CRM197 protein expression. The present invention relates to a method for producing CRM197 recombinant protein in cells. The method comprises culturing a cell that contains an expression plasmid with a polynucleotide and inducing the expression of the CRM197 protein. This innovation is crucial for advancing research in medical and pharmaceutical fields.
Career Highlights
I-Ming Cho is associated with Obi Pharma Inc., a company that focuses on developing innovative biopharmaceuticals. His role at the company has allowed him to work on cutting-edge projects that aim to improve health outcomes through advanced protein technologies.
Collaborations
Some of his notable coworkers include Chia-Hung Chiu and Lee-Cheng Liu. Their collaborative efforts contribute to the success of the projects at Obi Pharma Inc. and enhance the overall research environment.
Conclusion
I-Ming Cho's work in protein expression technology exemplifies the impact of innovative research in biotechnology. His contributions are paving the way for advancements in medical science and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile